He likes this company. It gives a good Canadian source dividend, and a company that is more than Canada on an energy standpoint. They’ve diversified into the US, so it's not just a Canadian pipeline. There are some catalysts in the next little while. The stock has been stuck around $60. Typically, you buy at $60 and sell at $65 so it looks interesting. Has a good 4% dividend yield that should grow. Probably $65-$70 is the next range for this stock.

This has been a mainstay in his energy growth portfolio. It has been a pretty good performer this year. The industry views this as a natural gas stock, but they have some very nice oil pools, more specifically liquid natural gas. This is why you have seen the stock start to pick up in the last week or so. Great management. If you are looking for a growth energy stock, which comes with the volatility, this would be a name. (See Top Picks.)

What is holding them back right now is the take away capacity, and a lot of maintenance on some of these collecting natural gas lines out west, which has affected production and volumes, and more specifically, a lot of that gas has been shut-in in storage, so you have a glut of gas which caused the AECO price to go to zero 2 weeks ago, but is now back to $1+. Also, one of its major shareholders sold down his holdings. He is waiting for clarity on AECO price, which we might get in the next couple of weeks.

A concern he has is the potential of a dividend cut in November. Most analysts are encouraging them to cut the dividend to help right side the ship. There is a lot of value in a company like this if they can turn it around. They started to turn the company around about 6 months ago, and doesn't think you are going to see much until Q4 of 2018. He would recommend buying half around the dividend cut. Being a tax loss candidate at the end of the year, Buy your 2nd half in late December, post tax loss selling, or early next year as you get more clarity. It sets up for a nice trade. Dividend yield of about 4.8%.

Zero rates are about to nudge higher and Quantitative Easing by buying bonds is starting to taper and unwind. The European Central Bank announced that instead of buying $60 billion of their bonds, they are now buying $30 billion each month, and that is going to zero by September of next year. Therefore, the thesis of gold going up in the next 18 months is going to look a lot different. The scenario of not trusting your own currency has a lot of bigger problems, and in that environment, this would be a higher risk stock. Don't be afraid of peeling off profits.

To him, the preferreds would be considered a high yield debt, so for that portion of your portfolio, you are probably OK. He would be hard pressed to envision this company filing for bankruptcy in the next couple of years, when the Government, especially the Québec government, always seems to have their back. Probably a safer way than playing the stock.

(A Top Pick Feb 8/17. Up 20%.) Still his favourite Pharma name. Had a small one-cell lung cancer solution, and the market is starting to get its head around that they are still in the game. We should get results in the 1st half of 2018. Over the next 5-6 years, their pipeline of drugs is so vast and undervalued, that as drugs come through fruition into cash flow and get approval, there are more and more tailwinds. It could be a potential take out candidate.